Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Hoosier Cancer Research Network
University Health Network, Toronto
Eastern Cooperative Oncology Group
Case Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
MacroGenics
University of Washington
Brigham and Women's Hospital
Weill Medical College of Cornell University
Merck Sharp & Dohme LLC
GERCOR - Multidisciplinary Oncology Cooperative Group
AIDS Malignancy Consortium
Instituto do Cancer do Estado de São Paulo
AIDS Malignancy Consortium
UNICANCER
Centre Hospitalier Universitaire de Besancon
Sun Yat-sen University
University of Cincinnati
Goethe University
Charite University, Berlin, Germany
M.D. Anderson Cancer Center
Inovio Pharmaceuticals
Eastern Cooperative Oncology Group
M.D. Anderson Cancer Center
Eastern Cooperative Oncology Group
Dana-Farber Cancer Institute
Translational Research in Oncology
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Advaxis, Inc.
Beijing Health Guard Biotechnology, Inc
AC Camargo Cancer Center
University Health Network, Toronto
AIDS Malignancy Consortium
University of California, San Francisco
Gruppo Oncologico del Nord-Ovest
Centre hospitalier de l'Université de Montréal (CHUM)
University of Iowa
Grupo Espanol Multidisciplinario del Cancer Digestivo
National Institutes of Health Clinical Center (CC)
ChineseAMS
Alliance for Clinical Trials in Oncology
Laser Surgery Care
Traws Pharma, Inc.
AIDS Malignancy Consortium
Royal Marsden NHS Foundation Trust
Sir Mortimer B. Davis - Jewish General Hospital
National Cancer Institute (NCI)